REGENERON PHARMACEUTICALS, INC for REGENERON PHARMACEUTICALS, INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Biodefense, FDA, national security, and privacy issues relating to biopharmaceutical manufacturers; tax and incentives; issues related to drug manufacturing and pricing; H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024; issues relating to pandemic preparedness and infectious disease education; issues relating to step therapy; issues relating to health care extenders; issues related to federal contracting relating to biopharmaceutical manufacturers
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYA BERMINGHAM | — |
| MADDIE DAVIDSON | — |
| EBEN DUROSS | — |
Medicare/Medicaid MMM
Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADDIE DAVIDSON | — |
| EBEN DUROSS | — |
| KATHERINE HADDAD | — |
Copyright/Patent/Trademark CPT
Patent issues relating to biopharmaceutical manufacturers; intellectual property rights; issues relating to WTO TRIPS waivers
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADDIE DAVIDSON | — |
| EBEN DUROSS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.